Home Fast Track My Amedeo FAQ About Flying Publisher   

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Diabetes
Subscription from Paris

Request access to your Amedeo Management Center.



Your AMEDEO page is free of charge.

This policy was made possible thanks to a media sponsorship by Boehringer Ingelheim.


2018-11-19

To download data for further processing, check single articles, then select "Medline format" and "Text only".

Abstract format   Medline format Web site   Text only

  1. Kmietowicz Z.
    SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation.
    BMJ. 2018;363:k4828.
    PubMed - Related Articles

  2. Iacobucci G.
    NHS England tells CCGs to end postcode lottery over diabetes glucose devices.
    BMJ. 2018;363:k4812.
    PubMed - Related Articles

  3. Ahola AJ, Harjutsalo V, Forsblom C, Saraheimo M, et al.
    Associations of dietary macronutrient and fibre intake with glycaemia in individuals with Type 1 diabetes.
    Diabet Med. 2018 Nov 13. doi: 10.1111/dme.13863.
    PubMed - Related Articles    Abstract available

  4. McArdle PD, Greenfield SM, Rilstone SK, Narendran P, et al.
    Carbohydrate restriction for glycaemic control in Type 2 diabetes: a systematic review and meta-analysis.
    Diabet Med. 2018 Nov 13. doi: 10.1111/dme.13862.
    PubMed - Related Articles    Abstract available

  5. Frodsham SG, Yu Z, Lyons AM, Agarwal A, et al.
    The Familiality of Rapid Renal Decline in Diabetes.
    Diabetes. 2018 Nov 13. pii: db18-0838. doi: 10.2337/db18-0838.
    PubMed - Related Articles    Abstract available

  6. Hughes FM Jr, Hirshman NA, Inouye BM, Jin H, et al.
    NLRP3 Promotes Diabetic Bladder Dysfunction and Changes in Symptom-Specific Bladder Innervation.
    Diabetes. 2018 Nov 13. pii: db18-0845. doi: 10.2337/db18-0845.
    PubMed - Related Articles    Abstract available

  7. Chai Z, Wu T, Dai A, Huynh P, et al.
    Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy.
    Diabetes. 2018 Nov 13. pii: db18-0712. doi: 10.2337/db18-0712.
    PubMed - Related Articles    Abstract available

  8. Arslanian S, Bacha F, Grey M, Marcus MD, et al.
    Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association.
    Diabetes Care. 2018 Nov 13. pii: dci18-0052. doi: 10.2337/dci18-0052.
    PubMed - Related Articles

  9. Guasch-Ferre M, Ruiz-Canela M, Li J, Zheng Y, et al.
    Plasma acylcarnitines and risk of type 2 diabetes in a Mediterranean population at high cardiovascular risk.
    J Clin Endocrinol Metab. 2018 Nov 13. pii: 5172268. doi: 10.1210/jc.2018-01000.
    PubMed - Related Articles    Abstract available

  10. Zheng JS, Imamura F, Sharp SJ, van der Schouw YT, et al.
    Association of plasma vitamin D metabolites with incident type 2 diabetes: EPIC-InterAct case-cohort study.
    J Clin Endocrinol Metab. 2018 Nov 9. pii: 5167366. doi: 10.1210/jc.2018-01522.
    PubMed - Related Articles    Abstract available

  11. Zheng D, Dou J, Liu G, Pan Y, et al.
    Association Between Triglyceride Level and Glycemic Control Among Insulin-treated Patients With Type 2 Diabetes.
    J Clin Endocrinol Metab. 2018 Nov 9. pii: 5167372. doi: 10.1210/jc.2018-01656.
    PubMed - Related Articles    Abstract available

  12. Zelniker TA, Wiviott SD, Raz I, Im K, et al.
    SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
    Lancet. 2018 Nov 9. pii: S0140-6736(18)32590.
    PubMed - Related Articles    Abstract available

  13. Wiviott SD, Raz I, Bonaca MP, Mosenzon O, et al.
    Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2018 Nov 10. doi: 10.1056/NEJMoa1812389.
    PubMed - Related Articles    Abstract available



Thank you for your interest in scientific medicine.


Design: